Breast Cancer Clinical Trial

Web-Based Communication Education for Breast Cancer Survivorship Care

Summary

This two-phase research plan will develop and test a culturally relevant, web-based patient education program, hereafter known as E-Talkcare. The intervention aims to empower Chinese cancer patients to effectively communicate with different providers in different healthcare settings.

View Full Description

Full Description

This two-phase study develops and tests the usability and efficacy of a culturally relevant, web-based patient education program, hereafter known as E-Talkcare, in improving Chinese immigrant breast cancer survivors' competence, perceived control, and self-efficacy in cancer care communication (intermediate outcomes), and patient-reported symptoms, adherence to breast cancer survivorship care guidelines, and quality of life (distal outcomes) versus the usual care control arm. In Phase I, community-based participatory research (CBPR) principles will be used to develop the intervention to educate participants about culture and communication by demonstrating how to ask for and verify information with doctors and use personalized symptom reports, and by providing question prompt lists for doctor visits. In Phase II, the intervention will be tested in a pilot randomized control trial (RCT). Using cases from Los Angeles Cancer Surveillance Program, California Cancer Registry, Maryland Cancer Registry, and clinics from California, 118 Chinese immigrant women (diagnosed with stage 0-III breast cancer and 1-3 years post-diagnosis) will be enrolled and randomized to either the E-Talkcare intervention or a usual care control arm. Participants will be interviewed via telephone at baseline (i.e., pre-randomization), 3-, and 6-months post-randomization.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Eligible Chinese women

≥ age 18
foreign-born speaking Mandarin and/or Cantonese,
diagnosed with breast cancer at stage 0, I, II or III,
1-3 years post-diagnosis and completed primary treatment (surgery, radiation, and chemotherapy); and
no recurrence, and 6) internet access.

Exclusion Criteria:

Women with other cancer types are ineligible due to different treatment complications.

Study is for people with:

Breast Cancer

Estimated Enrollment:

141

Study ID:

NCT03413332

Recruitment Status:

Recruiting

Sponsor:

Georgetown University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Georgetown University
Washington District of Columbia, 20007, United States More Info
Judy Wang, PhD
Contact
202-687-6306
[email protected]
Judy (Huei_Yu) Wang, Ph.D.
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

141

Study ID:

NCT03413332

Recruitment Status:

Recruiting

Sponsor:


Georgetown University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider